The MELimmune score-prognostic factors for overall survival in advanced melanoma and anti-PD-1 monotherapy-a multicentre, retrospective cohort study
MELimmune评分——晚期黑色素瘤和抗PD-1单药治疗患者总生存期的预后因素——一项多中心回顾性队列研究
期刊:ImmunoOncology and Technology
影响因子:
doi:10.1016/j.iotech.2025.101043
Lobo-Martins, S; Martins-Branco, D; Semedo, P M; Alvim, C M; Monteiro, A M; Vendrell, I; Gouveia, E; Passos, M J; Costa, L; Mansinho, A; de Sousa, R T
